AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Balance Sheet

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	12.1	11.11	12.04	4.75	7.94	3.21
Cash & Short-Term Investments	12.1	11.11	12.04	4.75	7.94	3.21
Cash Growth	13.22%	-7.72%	153.53%	-40.19%	147.43%	-47.56%
Accounts Receivable	36.95	43.2	41.01	39.62	29.87	29.23
Receivables	36.95	43.2	41.01	39.62	29.87	29.23
Inventory	57.84	48.48	49.06	42.4	33.5	33.65
Prepaid Expenses	-	5.37	3.22	7.1	6.14	1.81
Other Current Assets	0.09	0.19	0.41	0.74	0.1	-
Total Current Assets	106.98	108.34	105.73	94.6	77.54	67.9
Property, Plant & Equipment	3.6	3.25	3.82	3.37	3.36	3.79
Other Intangible Assets	60.37	13.74	14.45	16.17	15.99	15.59
Long-Term Deferred Tax Assets	0.67	-	2.25	4.47	8.33	0.72
Long-Term Deferred Charges	-	44.49	39.01	29.46	22.11	17.13
Total Assets	171.62	169.82	165.26	148.06	127.32	105.13
Accounts Payable	27.68	25.12	25.33	22.19	12.07	14.7
Accrued Expenses	6.09	9.8	11.85	9.57	8.11	7.62
Short-Term Debt	1.16	1.08	-	1.46	-	-
Current Portion of Long-Term Debt	32.99	-	-	1	4	5.16
Current Portion of Leases	0.85	0.73	0.8	0.57	0.54	0.61
Current Income Taxes Payable	2	2.68	3.8	0.83	0.84	-
Other Current Liabilities	-	3.86	4.29	4.16	3.48	4.01
Total Current Liabilities	70.76	43.26	46.07	39.78	29.05	32.1
Long-Term Debt	-	25.6	28.2	32.2	33.2	33.2
Long-Term Leases	2.87	2.59	3.19	2.82	2.77	3.24
Long-Term Deferred Tax Liabilities	-	1.3	-	-	-	-
Total Liabilities	73.64	72.74	77.46	74.8	65.02	68.54
Common Stock	78.24	78.24	78.24	78.24	80.77	80.36
Retained Earnings	20.95	19.54	9.26	-5.2	-15.85	-41.26
Comprehensive Income & Other	-0.07	-0.14	0.3	0.23	-2.61	-2.51
Total Common Equity	99.12	97.64	87.8	73.27	62.31	36.59
Minority Interest	-1.14	-0.56	-	-	-	-
Shareholders' Equity	97.99	97.08	87.8	73.27	62.31	36.59
Total Liabilities & Equity	171.62	169.82	165.26	148.06	127.32	105.13
Total Debt	37.87	30	32.19	38.05	40.51	42.22
Net Cash (Debt)	-25.77	-18.89	-20.15	-33.3	-32.57	-39.01
Net Cash Per Share	-0.25	-0.18	-0.19	-0.32	-0.31	-0.38
Filing Date Shares Outstanding	109.93	104.87	104.87	104.87	104.71	104.64
Total Common Shares Outstanding	109.93	104.87	104.87	104.87	104.7	104.58
Working Capital	36.22	65.09	59.66	54.83	48.49	35.8
Book Value Per Share	0.90	0.93	0.84	0.70	0.60	0.35
Tangible Book Value	38.75	83.9	73.34	57.1	46.32	21
Tangible Book Value Per Share	0.35	0.80	0.70	0.54	0.44	0.20
Machinery	-	2.43	2.15	2.02	2.05	1.72

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.